Congratulations to our new Professors, Associate Professors and University Research Lecturers

Congratulations to:

Anne Kiltie who has been awarded the title of Professor of Experimental Clinical Oncology.

Geoff Higgins, Somnath Mukherjee, Wojciech Niedzwiedz and Andrew Protheroe who have all been awarded Associate Professorships. 

Bart Conelissen on becoming a University Research Lecturer. 

Academy of Medical Sciences honours eight Oxford researchers

Professor Tim Maughan, from the CRUK/MRC Oxford Institute for Radiation Oncology, has been named among the eight medical researchers at Oxford University who have been elected as Fellows of the Academy of Medical Sciences.  The honour recognises outstanding contribution to the advancement of medical science, innovative application of scientific knowledge, or conspicuous service to healthcare.

Oxford scientists lead the way in cutting-edge cancer research

Oxford scientists will play a key role in ground-breaking research into new radiotherapy and immunotherapy treatments for cancer patients following a multi-million pound investment.

Researchers from the city’s Cancer Research UK Centre will be collaborating with scientists across the UK, following the announcement today of the charity’s Centres’ Network Accelerator Awards.

Designed to inspire new approaches to beating cancer, the awards will invest around £16 million UK-wide over the next five years.

Oxford researcher secures funding for powerful imaging technique in pancreatic cancer

Pancreatic Cancer Research Fund (PCRF) is funding six new research projects with a total of £1 million - bringing the charity’s support for research into the UK’s most lethal cancer to over £8 million. This is the third year that PCRF has invested £1 million in a single funding round. In total, the charity has funded 40 cutting edge research projects across the UK and Ireland, worth over £6 million.

Early signs of success for pioneering treatment at Oxford Early Phase Clinical Trials Unit

An Oxford cancer patient who was told she may have only eighteen months to live is free from signs of the disease after taking a trial drug for almost three years. Susan Cakebread received her pioneering treatment at the Early Phase Clinical Trials Unit at Oxford’s Churchill Hospital which aims to discover new treatments for the future.


About Us
We aim to enhance clinical and basic cancer research in Oxford with the ultimate goal of increasing cancer cure rates.
In Oxford, we have a great wealth of broad-ranging expertise and a powerful network of cancer researchers.
Study With Us
Our graduate training programmes for both scientists and clinicians are internationally recognised.
Subscribe to RSS - News